Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
51
NCT02506452
Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2015
Completion: Dec 31, 2017